USANA Health Sciences, Inc. USNA

14.50 0.24 1.68% as of 25 Sep
Market cap
$263.5M
P/E
0.0×

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Revenue

+8 more quarters

213.67 226.20 250.22 223.27
Revenue Growth 6.72% 5.89% 0.27% (5.33%)
Cost of Revenue 48.82 49.41 59.44 48.34
Gross Profit 164.86 176.79 190.78 174.93
SG&A Expenses 163.63 166.01 176.91 165.79
Operating Income 1.22 3.82 13.87 (20.00)
Non-operating Interest Expenses 0.05 0.12 0.24 —
Non-operating Income/Expense 0.57 0.36 1.59 1.10
EBT 1.79 4.18 15.47 (18.90)
Income Tax Provision 8.46 5.77 8.51 9.05
Income after Tax (6.66) (1.59) 6.96 (27.95)
Dividends (Preferred) 0.00 0.00 0.00 —
Non-Controlling Interest (0.14) 0.18 (0.56) (6.57)
Net Income Common (6.52) (1.77) 7.52 (21.38)
EPS (Basic) (0.36) (0.10) 0.41 (1.16)
EPS (Diluted) (0.36) (0.10) 0.41 (1.16)
Shares (Basic, Weighted) 18.29 18.54 18.40 18.49
Shares (Diluted, Weighted) 18.29 18.57 18.41 18.49
Gross Margin 77.15% 78.16% 76.25% 78.35%
EBIT Margin 0.57% 1.69% 5.54% (8.96%)
EBT margin 0.84% 1.85% 6.18% (8.46%)
Net Profit Margin (3.05%) (0.78%) 3.00% (9.58%)
EBITDA 10.79 14.11 23.66 18.31
EBIT 1.22 3.82 13.87 (20.00)
Income from Continuous Operations (6.66) (1.59) 6.96 (27.95)
Consolidated Net Income/Loss (6.66) (1.59) 6.96 (27.95)
EPS (Basic, from Continuous Ops) (0.36) (0.07) 0.38 (1.51)
EPS (Diluted, from Cont. Ops) (0.36) (0.07) 0.38 (1.51)
EPS (Basic, Consolidated) (0.36) (0.07) 0.38 (1.51)
EPS (Diluted, Consolidated) (0.36) (0.07) 0.38 (1.51)
Shares (Diluted, Average) 18.29 18.30 18.41 18.49
EBITDA Margin 5.05% 6.24% 9.46% 8.20%
Operating Cash Flow Margin (0.92%) (1.50%) 3.90% 10.44%

Fold the line items

In millions of $ except per-share values · columns are period end dates